Nissor Website Global Presence

Human Normal Immunoglobulin for I.V Use (5% I.P.)

  • Immusor is developed using technology that involves an integrated end to end chromatography process for plasma proteins.
  • The traditional method used by other manufacturers is the Cohn’s process of fractionation with ethanol, which is an older technology with less yield and lower purity.
  • Immusor is formulated from plasma which is NAT tested and negative for HIV-1, HIV-2, HBV and HCV.
  • In addition, two more orthogonal steps are included in the manufacturing process for virus inactivation/removal.
  • Immusor is prepared using new, patented technology which has been granted three US patents.
  • Immusor is fully complaint with Indian pharmacopeia.

Manufactured from Indian Human Plasma

Non reactive for HBsAG, HCV, HIV 1 & 2 antibodies

Negative for HIIV 1 & 2, HCV and HBV by NAT

Suitable for administration to patients undergoing dialysis or to premature infants

Serum albumin, human 20g

Sodium caprylate 0.016M

N- Acetyl-DL-tryptophan 0.016M

Sodium n0t more than 160 mmol/L

Potassium not more than 2mmol/L

Aluminium not more than 200 ug/L

No preservatives

To be sold by retail on the prescription of a registered medical practitioner only

© Copyright Nissor Pharmaceuticals 2021 / All Rights Reserved.

Designed By Galagali Multimedia.